Synthesis and evaluation of cytotoxicity of stilbene analogues

Archives of Pharmacal Research

Volumn 26, Issue 4, 2003, Pages 253-257

  Sang, Kook Lee ^a   Kyung, Ae Nam ^b   Yeon, Hoi Hoe ^b   Min, Hye Young ^b   Kim, Eun Young ^b   Ko, Hyojin ^b   Song, Soyoung ^b   Lee, Taeho ^b   Kim, Sanghee ^b  

^a Ewha Womans University   (South Korea)

^b Seoul National University   (South Korea)

Author keywords

Cytotoxicty; Resveratrol analogues; Stilbene analogues

Indexed keywords

ANTINEOPLASTIC AGENT; PHYTOALEXINS; PLANT EXTRACT; RESVERATROL; STILBENE DERIVATIVE; TERPENE;

ARTICLE; CELL CULTURE; COLON TUMOR; DRUG SCREENING; HUMAN; IN VITRO STUDY; LUNG TUMOR; PATHOLOGY; STRUCTURE ACTIVITY RELATION; SYNTHESIS;

ANTINEOPLASTIC AGENTS; COLONIC NEOPLASMS; DRUG SCREENING ASSAYS, ANTITUMOR; HUMANS; LUNG NEOPLASMS; PLANT EXTRACTS; STILBENES; STRUCTURE-ACTIVITY RELATIONSHIP; TERPENES; TUMOR CELLS, CULTURED;

EID: 0642312373     PISSN: 02536269     EISSN: 02536269     Source Type: Journal    
DOI: 10.1007/bf02976951     Document Type: Article

References (19)

1. Alonso, E., Ramón, D. J., and Yus, M., Simple synthesis of 5-substituted resorcinols: A revisited family of interesting bioactive molecules. J. Org. Chem., 62, 417-421 (1997).
2. Bellucci, G., Chiappe, C., and Moro, G. L., Crown ether catalyzed stereospecific synthesis of Z- and E-stilbenes by wittig reaction in a solid-liquid two-phases system. Tetrahedron Lett., 37, 4225-4228 (1996).
3. Fontecave, M., Lepoivre, M., Elleingand, E., Gerez, C., and Guittet, O., Resveratrol, a remarkable inhibitor of ribonucleotide reductase. FEBS Lett., 421, 277-279 (1998).
4. Frankel, E. N., Waterhouse, A. L., and Kinsella, J. E., Inhibition of human LDL oxidation by resveratrol. Lancet., 341, 1103-1104 (1993).
5. Jang, D. O., Park, D. J., and Kim, J. A., Mild and efficient procedure for the preparation of acid chlorides from carboxylic acids. Tetrahedron Lett., 40, 5323-5326 (1999).
6. Jang, M., Cai, L, Udeani, G. O., Slowing, K. V., Thomas, C. F., Beecher, C. W. W., Fong, H. S. S., Farnsworth, N. R., Kinghorn, A. D., Mehta, R. G., Moon, R. C., and Pezzuto, J. M., Cancer chemopreventive activity of resveratrol, a natural product derived from grapes. Science, 275, 218-220 (1997).
7. Kucerovy, A., Li, T., Prasad, K., Repiè, O., and Blacklock, T. J., An efficient large-scale synthesis of methyl 5-[2-(2,5-dimethoxyphenyl)ethyl]- 2-hydroxybenzoate. Org. Process Res. Dev., 1, 287-293 (1997).
8. Lee, S. K., Cui, B., Mehta, R. R., Kinghorn, A. D., and Pezzuto, J. M., Cytostatic mechanism and antitumor potential of novel 1 H-cyclopenta[b] benzofuran lignans isolated from Aglaia elliptica. Chem-Biol. Interact., 115, 215-228 (1998).
9. Mgbonyebi, O. P., Russo, J., and Russo, I. H., Antiproliferative effect of synthetic resveratrol on human breast epithelial cells. Int. J. Oncol., 12, 865-869 (1998).
10. Ohsumi, K., Hatanaka, T., Fujita, K., Nakagawa, R., Fukuda, Y., Nihei, Y., Suga, Y., Morinaga, Y., Akiyama, Y., and Tsuji, T., Syntheses and antitumor activity of cis-restricted combretastatins: 5-membered heterocyclic analogues. Bioorg. Med. Chem. Lett., 8, 3153-3158 (1998).
11. Orsini, F., Pelizzoni, F., Bellini, B., and Miglierini, G., Synthesis of biologically active polyphenolic glycosides (combretastatin and resveratrol series). Carbohyd. Res., 301, 95-109 (1997).
12. Pace-Asciak, C. R., Hahn, S., Diamandis, E. P., Soleas, G., and Goldberg, D. M., The red wine phenolics trans-resveratrol and quercetin block human platelet aggregation and eicosanoid synthesis: implications for protection against coronary heart disease. Clin. Chim. Acta, 235, 207-219 (1995).
13. Park, J., Choi, Y., Jang, M., Lee, Y., Jun, D., Suh, S., Baek, W., Suh, M., Jin, I., and Kwon, T. K., Chemopreventive agent resveratrol, a natural product derived from grapes, reversibly inhibits progression through S and G2 phases of the cell cycle in U937 cells. Cancer Lett., 163, 43-49 (2001).
14. Pettit, G. R., Singh, S. B., Boyd, M. R., Hamel, E., Pettit, R. K., Schmidt, J. M., and Hogan, F., Antineoplastic agents. 291. Isolation and synthesis of combretastatins A-4, A-5, and A-6. J. Med. Chem., 38, 1666-1672 (1995).
15. Pettit, G. R., Lippert III, J. W., and Herald, D. L., A Pinacol Rearrangement/Oxidation Synthetic Route to Hydroxyphenstatin. J. Org. Chem., 65, 7438-444 (2000).
16. Skehan, P., Storeng, R., Scudiero, D., Monks, A., McMahon, J., Vistica, D., Warren, T. W., Bokesch, H., Kenney, S., and Boyd, M. R., New colorimetric cytotoxicity assay for anticancer-drug screening. J. Natl. Cancer Inst., 82, 1107-1112 (1990).
17. Uenobe, F., Nakamura, S., and Miyazawa, M., Antimutagenic effect of resveratrol against Trp-P-1. Mutat. Res., 373, 197-200 (1997).
18. Wilds, A. L. and MaCormack, W. B., Hexahydro derivatives of meso-hexestrol. J. Am. Chem. Soc., 70, 4127-4132 (1948).
19. Zhang, J. T., Dai, W., and Harvey, R. G., Synthesis of higher oxidized metabolites of dibenz[ a, j]anthracene implicated in the mechanism of carcinogenesis. J. Org. Chem., 63, 8125-8132 (1998).